Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC22A18 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | LGR5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ANXA7 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | CHMP4C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | DLEC1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SNX20 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | UBALD1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | GOLGA3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | KLHL6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | TAS2R9 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |